Eikon Therapeutics, Inc. (EIKN) News
Track canonical SquawkNews coverage tagged to EIKN, Eikon Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 8 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Eikon Therapeutics appoints Ching-Pin Chang as EV P and CSO
Eikon Therapeutics announced the appointment of Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer.
EQUITY | Sep 03, 2026, 11:38 AM UTC
L
Eikon Therapeutics appoints Ching-Pin Chang as EVP and CSO
Eikon Therapeutics appointed Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer.
EQUITY | Sep 03, 2026, 11:30 AM UTC
L
Eikon Therapeutics to participate in investor conferences in September 2026
Eikon Therapeutics said it will participate in investor conferences during September 2026.
EQUITY | Aug 26, 2026, 11:30 AM UTC
L
Eikon Therapeutics to Participate in Cantor KOL PARP-Inhibitor Event
Eikon Therapeutics (EIKN) says it will participate in a KOL event on the therapeutic use of PARP inhibitors in oncology hosted by Cantor Fitzgerald.
EQUITY | Aug 18, 2026, 08:15 PM UTC
L
Eikon Therapeutics reports Q2 2026 results and clinical updates
Eikon Therapeutics (EIKN) reports second quarter 2026 financial results and provides clinical updates, according to a TradeXchange Newsdesk release.
EARNINGS | Aug 13, 2026, 08:02 PM UTC
L
EIKN shares rise 10% after the company dosed the first patient in a key registrational trial for its first-line therapy lung cancer treatmen
EIKN shares rise 10% after the company dosed the first patient in a key registrational trial for its first-line therapy lung cancer treatment.
EQUITY | Jul 27, 2026, 02:24 PM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Thursday's after-market session, with Shuttle Pharmaceuticals and INVO Fertility among the gainers and Creative Medical Tech and Catheter Precision among the losers
EQUITY | Jun 25, 2026, 09:05 PM UTC
L
EIKN Joins Russell 3000
Eikon Therapeutics to join the Russell 3000 Index, reflecting progress as a publicly traded company
EQUITY | Jun 25, 2026, 08:15 PM UTC